Hai-ting Liu
Key Laboratory For Experimental Teratology Of The Ministry Of Education And Department Of Pathology
Jinan, 250012, China
Jinan, 250012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression.
Journal: Cell death and differentiation
Published: March 25, 2023
CircKDM4B suppresses breast cancer progression via the miR-675/NEDD4L axis.
Journal: Oncogene
Published: March 09, 2021
lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.
Journal: Cell death and differentiation
Published: January 21, 2021
Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response.
Journal: Pathology oncology research : POR
Published: January 16, 2021
TIPRL, a Novel Tumor Suppressor, Suppresses Cell Migration, and Invasion Through Regulating AMPK/mTOR Signaling Pathway in Gastric Cancer.
Journal: Frontiers in oncology
Published: March 27, 2020
E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
Journal: Molecular oncology
Published: December 26, 2019
LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
Journal: British journal of cancer
Published: June 12, 2019
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
Journal: Cancer research
Published: April 05, 2018
Last Updated: 09/26/2026